Probably a good idea, CDY doesn't have a good reputation.
More is needed though to attain maximum leverage from this change.
I think Nikki Somerset should be pushed up the tree to be head of sales and distribution, BCL operate a different mind set to the Cellmid team. I think Cellmid have done a good job developing product for their target markets but just can't sell, for that matter manage a P&L.
That's why I remain a buy, if that happens this will fly.
Ann: Notice of Annual General Meeting/Proxy Form, page-4
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1199234 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable